
This scoping review examined participant characteristics in U.S.-based clinical trials investigating hearing aids (HA) and cochlear implants (CI) regarding cognitive decline. The study found significant racial/ethnic disparities, with White participants overrepresented (92.1%) compared to Black, Asian, and Hispanic/Latino populations. The study highlights the need for systemic efforts to increase diversity in clinical trials to improve understanding of how hearing loss treatments impact cognitive decline across various demographic groups.
Like
Save
Share